Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant
Condition(s):Hematologic Malignancies; Graft vs Host DiseaseLast Updated:April 11, 2014Completed
Hide Studies Not Open or Pending
Condition(s):Hematologic Malignancies; Graft vs Host DiseaseLast Updated:April 11, 2014Completed
Condition(s):Graft-versus-host-disease; Graft Vs Host DiseaseLast Updated:May 10, 2023Completed
Condition(s):Graft-versus-Host DiseaseLast Updated:December 11, 2013Terminated
Condition(s):Graft Vs Host DiseaseLast Updated:August 28, 2023Terminated
Condition(s):Graft Vs Host DiseaseLast Updated:June 24, 2005Completed
Condition(s):Chronic Graft vs Host DiseaseLast Updated:May 23, 2022Completed
Condition(s):Graft vs Host DiseaseLast Updated:November 7, 2006Completed
Condition(s):Graft-vs-Host DiseaseLast Updated:July 19, 2012Completed
Condition(s):Graft-vs-Host Disease; GVHDLast Updated:July 26, 2018Terminated
Condition(s):Graft-vs-host DiseaseLast Updated:November 30, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.